Triumeq and Panic attack - a phase IV clinical study of FDA data

Summary:

Panic attack is reported as a side effect among people who take Triumeq (abacavir sulfate; dolutegravir sodium; lamivudine), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Truvada, and have Fatigue.

The phase IV clinical study analyzes which people have Panic attack when taking Triumeq. It is created by eHealthMe based on reports of 6,839 people who have side effects when taking Triumeq from the FDA, and is updated regularly.

What is Triumeq?

Triumeq has active ingredients of abacavir sulfate; dolutegravir sodium; lamivudine. It is often used in hiv infection. eHealthMe is studying from 6,900 Triumeq users. Check the latest studies of Triumeq.

What is Panic attack?

Panic attack is found to be associated with 2,351 drugs and 2,081 conditions by eHealthMe. Check the latest studies of Panic attack.

On Jun, 24, 2026

6,839 people reported to have side effects when taking Triumeq.
Among them, 28 people (0.41%) have Panic attack.

Among these 28 people:

How long have people been on Triumeq when they have Panic attack? *

What is the gender of people who have Panic attack when taking Triumeq? *

female: 0.0 %
male: 100 %

What is the age of people who have Panic attack when taking Triumeq? *

What are other drugs people take besides Triumeq? *

What are other side effects people have besides Panic attack? *

Stress And Anxiety: 13 people, 46.43%
Depression: 12 people, 42.86%
Pain: 9 people, 32.14%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 9 people, 32.14%
Emotional Distress: 9 people, 32.14%
Insomnia (sleeplessness): 8 people, 28.57%
Muscle Aches (muscle pain): 6 people, 21.43%
Fatigue (feeling of tiredness): 6 people, 21.43%
Dyspnea (difficult or laboured breathing): 5 people, 17.86%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 14.29%

What are the existing conditions these people have? *

Weakness: 3 people, 10.71%
Sensation Of Blood Flow: 3 people, 10.71%
Bone Pain: 3 people, 10.71%
Osteoporosis (bones weak and more likely to break): 3 people, 10.71%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 10.71%
Irritable Bowel Syndrome: 3 people, 10.71%
Fatigue (feeling of tiredness): 3 people, 10.71%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 2 people, 7.14%
Dry Eyes (lack of adequate tears): 2 people, 7.14%
High Blood Pressure: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Triumeq and have Panic attack?

- Check whether Panic attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Triumeq:

Triumeq (6,900 reports)

Panic attack treatments and more:

Panic attack (65,704 reports)

How severe was Panic attack and when was it recovered:

Panic attack in Triumeq

Expand to all the drugs that have ingredients of abacavir sulfate; dolutegravir sodium; lamivudine:

Panic attack and drugs with ingredients of abacavir sulfate; dolutegravir sodium; lamivudine (6 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Triumeq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panic attack:

Panic attack (2,351 drugs)

Browse all the conditions that are associated with Panic attack:

Panic attack (2,081 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate; dolutegravir sodium; lamivudine (the active ingredients of Triumeq) and Triumeq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.